- Innovative Delivery Systems for Technology Landscape🔍
- Emerging Technologies Are Driving the Future of Pharma🔍
- The Current Trends and Challenges Influencing the Oral Solid Dose ...🔍
- Implementation of Quality by Design 🔍
- The latest innovations for enteric coatings🔍
- Overcoming Challenges in the Formulation Development of Oral ...🔍
- What does 2023 hold for oral solid dosage forms?🔍
- Enabling modular dosage form concepts for individualized multidrug ...🔍
A review of emerging technologies enabling improved solid oral ...
Innovative Delivery Systems for Technology Landscape | Unitaid
Emerging Technology toPrepare Solid Dispersions with. Enhanced Oral Bioavailability of Poorly Water Soluble. Drugs. Molecules 2019; 24: 3471. 83 Mohylyuk V ...
OSD soars: Advancements in oral solid dose - Pharma Manufacturing
The compressed form of today's oral solid dose (OSD) medications can be attributed to a 19th century artist's desire to improve upon a ...
Emerging Technologies Are Driving the Future of Pharma
“A New Chapter In Pharmaceutical Technology: 3D Printing For Solid Oral Dosage Forms.” AAPS Blog. 9 Nov. 2016. Web. Mike Fisher ...
The Current Trends and Challenges Influencing the Oral Solid Dose ...
Increasing Bioavailability: Excipients can be used to help enhance solubility or absorption of the API in the human body. ○ Enabling fixed-dose ...
Implementation of Quality by Design (QbD) for development of ...
The main objective of this review is to establish the basis for the ... A review of emerging technologies enabling improved solid oral ...
The latest innovations for enteric coatings, delivery technologies and ...
... oral solid dosage form. In this webinar, speakers will review how to increase the flexibility of functional coatings or enable rapid ...
Overcoming Challenges in the Formulation Development of Oral ...
A key concern when developing an oral solid dosage form comes from generating a therapeutic which can be absorbed into the bloodstream and ...
What does 2023 hold for oral solid dosage forms?
excipients to support enhanced controlled release, enabling more effective fixed-dose combination and long-acting OSD products; this is in ...
Enabling modular dosage form concepts for individualized multidrug ...
... better match emerging ... Better Medicines for Older Patients: Considerations between Patient Characteristics and Solid Oral Dosage Form Designs ...
Developing Solid Oral Dosage Forms - 2nd Edition - Elsevier Shop
Chapters have been added, combined, deleted, and completely revised as necessary to produce a comprehensive, well-organized, valuable reference ...
Excipients and their Functionality for Enabling Technologies in Oral ...
Summary Over the years, excipients have undergone a paradigm shift from being “inert ingredients” to “functional ingredients” in a dosage ...
Does the Formulation of Oral Solid Dosage Forms Affect Acceptance ...
Further work is needed to identify the characteristics of oral solid dosage forms that will improve patient acceptance and adherence. The aim of ...
Trends In Solid Oral Dosage Delivery | Contract Pharma
In the cluttered pharma market, to gain a competitive advantage or enhance existing formulations, there is an increased focus on developing 505( ...
Four Quick Questions: Solid Dosage Research & Development
One is the new Initia capsule filler, a tabletop unit for laboratories focusing on dosator technology. The module is designed to fill up to 5 ...
Emerging Technologies Advance Oral Drug Delivery - PharmTech
... Technology-06-02-2018, Volume 42, Issue 6. Pages: 18–20. New approaches enable more patient-centric drug design that offers improved outcomes.
INNOVATIVE DEVELOPMENT AND PRODUCTION OF IMMEDIATE ...
... developing useful products. One such application is the development of immediate release pharmaceutical oral solid dosage forms (tablets) for treating illnesses ...
Working together, we can reimagine medicine to improve and extend people's lives.
Crinetics - Developing Therapies For Endocrine Diseases
... Solid-Tumors. Discovery, IND-enabling, Phase 1, Phase 2, Phase 3, Approved. Paltusotine (SST2 Agonist) Acromegaly. Carcinoid Syndrome. Atumelnant (Oral ACTH ...
Enabling technologies driving drug research and development
The analysis shows large variations in the appearance of the various innovative technologies in the different studied data sources, which provided valuable ...